Scholarlink

<p>The pathological progression of diabetic periodontitis is closely associated with macrophage functional imbalance induced by a high-glucose environment. High glucose significantly upregulates IL-1β and other pro-inflammatory factors by activating NLRP3 inflammasomes in macrophages, exacerbating periodontal tissue inflammation and suppressing osteoblast activity. Extracellular vesicles derived from M2-type macrophages (M2-EVs) effectively inhibit NLRP3 inflammasome activation and ameliorate macrophage polarisation imbalance through their natural inflammatory targeting affinity and miR-23a-3p-mediated negative regulation of NEK7. The M2-EVs/PDA/GelMA hydrogel developed in this study enables controlled release via a dynamic network structure, significantly reducing NLRP3 and IL-1β expression in periodontal tissues while promoting bone marrow stromal cell (BMSC) osteogenic differentiation through reparative macrophage-mediated secretion of osteoinductive factors, ultimately achieving periodontal bone repair and regeneration. This strategy establishes a novel multifunctional biomaterial platform for diabetic periodontitis treatment by integrating immune modulation and bone regeneration mechanisms, demonstrating significant potential for clinical translation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

M2 macrophage-derived extracellular vesicle/polydopamine hydrogel attenuates diabetic periodontitis-induced bone loss via the NEK7/NLRP3/IL−1β pathway

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月29日

查看全文
  • Yuzhao Cheng,
  • Pengyu Zhao,
  • Na Zhang,
  • Jiehua Guo,
  • Jiao Niu,
  • Fenglan Li

摘要

The pathological progression of diabetic periodontitis is closely associated with macrophage functional imbalance induced by a high-glucose environment. High glucose significantly upregulates IL-1β and other pro-inflammatory factors by activating NLRP3 inflammasomes in macrophages, exacerbating periodontal tissue inflammation and suppressing osteoblast activity. Extracellular vesicles derived from M2-type macrophages (M2-EVs) effectively inhibit NLRP3 inflammasome activation and ameliorate macrophage polarisation imbalance through their natural inflammatory targeting affinity and miR-23a-3p-mediated negative regulation of NEK7. The M2-EVs/PDA/GelMA hydrogel developed in this study enables controlled release via a dynamic network structure, significantly reducing NLRP3 and IL-1β expression in periodontal tissues while promoting bone marrow stromal cell (BMSC) osteogenic differentiation through reparative macrophage-mediated secretion of osteoinductive factors, ultimately achieving periodontal bone repair and regeneration. This strategy establishes a novel multifunctional biomaterial platform for diabetic periodontitis treatment by integrating immune modulation and bone regeneration mechanisms, demonstrating significant potential for clinical translation.